GLP-1 Receptor Agonists and Cardiovascular Outcomes

Learn about GLP-1 Receptor Agonists (GLP-1 RAs) in clinical practice and the cardiovascular and heart failure outcomes associated with this important hormone.

Diabetes, Heart Failure, Pharmacology
Member Cost: $0Non-member Cost: $0
Credits: 0.50 CE contact hours, 0.50 CE pharmacology hours

Course Overview

In this free pharmacology continuing education course, Eryn Bryant, RN, MS, ANP discusses the use of GLP-1 Receptor Agonists (GLP-1 RAs) in clinical practice. This CE course describes the cardiovascular and heart failure outcomes associated with this important hormone.

Register

Learning Objectives

  1. Review the cardiovascular burden for people with type 2 diabetes.
  2. Describe the clinical efficacy and safety profile of GLP-1 Receptor Agonists (GLP-1 RAs)
  3. Interpret cardiovascular and heart failure outcomes associated with GLP-1 RAs.
  4. Demonstrate prudent use of GLP-1 RAs in clinical practice.

Faculty

Eryn Bryant, RN, MS, ANP